Windtree Therapeutics Pioneers BNB Adoption with $200M Crypto Strategy
Windtree Therapeutics has announced a landmark move to become the first NASDAQ-listed company to gain exposure to BNB, signaling a significant step towards institutional cryptocurrency adoption. The biopharmaceutical firm has entered into an initial $60 million agreement with Build and… Read More »Windtree Therapeutics Pioneers BNB Adoption with $200M Crypto Strategy